Canadian healthcare executive John Thomas Howard was arrested on November 8 in the tunnel connecting Detroit and Canada, facing federal charges of smuggling, conspiracy, and importing a misbranded drug for patient use in the United States, CNBC reported.
Howard serves as treasurer and director for CANARX, a Windsor, Ontario firm established in 2002.
Federal authorities are also seeking his brother, company president Bob Howard, on similar charges according to court records. The prosecution marks the first criminal case brought by U.S. authorities against a company operating within the alternative funding program industry, which promises to lower prescription drug costs by sourcing medications from international markets.
The Food and Drug Administration and the Department of Homeland Security maintain that this business model violates federal law and exposes patients to unregulated foreign drugs and counterfeit products. While alternative funding programs typically argue that personal medication importation is permissible under U.S. law, investigators contend these commercial operations exceed those legal boundaries.
Legal representation for CANARX responded to the indictment by defending the firm’s operations. The Howard brothers “deny all the charges against them, will defend vigorously, and expect to be vindicated in court,” Joseph Morris, general counsel for CANARX, told CNBC.
The federal case originated from a tip regarding a separate Florida-based operation named ScriptSourcing, according to a 35-page affidavit dated October 29 and written by Dustin Dobbs, a special agent with the FDA’s Office of Criminal Investigations. Based in Bonita Springs, ScriptSourcing marketed international prescriptions to self-funded employer health plans under founder and chief executive Gary Becker.

Federal agents targeted ScriptSourcing after receiving reports of patient harm linked to its international supply chain. The affidavit details two incidents from 2025, including a patient hospitalized with a small bowel obstruction after using misbranded Mounjaro sourced through a Canadian pharmacy, and another individual seriously injured by a counterfeit product.
Faced with mounting regulatory pressure, Becker agreed to cooperate with federal investigators by May 2026. Becker told the FDA that CANARX provided his company with a operational roadmap for importing foreign medications, according to court documents. Financial records provided by ScriptSourcing showed approximately 16,549 prescription drugs dispensed through transactions with CANARX between 2021 and 2026.
"U. S. authorities are accusing the two top officials of a Canadian company of operating a long-running scheme to illegally import prescription drugs into the U. S., according to court records." John Thomas Howard, treasurer and a director of the company, CANARX, was arrested… https://t.co/v9P1pdTGTX
Recorded phone calls between June and July 2026 captured Becker discussing foreign import routes with the Howard brothers. The conversations demonstrated that John Howard understood the illegal nature of the importation routes and actively adapted them for CANARX operations, according to Agent Dobbs.
Gilead Sciences filed a civil lawsuit in December 2024 alleging that CANARX and other operators illegally imported its HIV medication Biktarvy.

“Pharmaceuticals manufactured for foreign markets are almost always considered unapproved and misbranded drugs under U.S. law, whether counterfeit or even if made by the same manufacturer that produced the version sold in the United States” Dustin Dobbs, special agent with the FDA's Office of Criminal Investigations, wrote in his affidavit.
George Karavetsos, attorney for ScriptSourcing founder Gary Becker, confirmed that the partnership has ceased operations, declining further comment on the unsealed affidavit. The FDA did not respond to requests for comment regarding the specific details contained in Agent Dobbs’ filings.
Worth a look